CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
- 15 January 2013
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 73 (2) , 571-582
Abstract
CXCR2 in non–small cell lung cancer (NSCLC) has been studied mainly in stromal cells and is known to increase tumor inflammation and angiogenesis. Here, we examined the prognostic importance of CXCR2 in NSCLC and the role of CXCR2 and its ligands in lung cancer cells. The effect of CXCR2 expression on tumor cells was studied using stable knockdown clones derived from a murine KRAS/p53–mutant lung adenocarcinoma cell line with high metastatic potential and an orthotopic syngeneic mouse model and in vitro using a CXCR2 small-molecule antagonist (SB225002). CXCR2 protein expression was analyzed in tumor cells from 262 NSCLC. Gene expression profiles for CXCR2 and its ligands (CXCR2 axis) were analyzed in 52 human NSCLC cell lines and 442 human lung adenocarcinomas. Methylation of CXCR2 axis promoters was determined in 70 human NSCLC cell lines. Invasion and metastasis were decreased in CXCR2 knockdown clones in vitro and in vivo. SB225002 decreased invasion in vitro. In lung adenocarcinomas, CXCR2 expression in tumor cells was associated with smoking and poor prognosis. CXCR2 axis gene expression profiles in human NSCLC cell lines and lung adenocarcinomas defined a cluster driven by CXCL5 and associated with smoking, poor prognosis, and RAS pathway activation. Expression of CXCL5 was regulated by promoter methylation. The CXCR2 axis may be an important target in smoking-related lung adenocarcinoma. Cancer Res; 73(2); 571–82. ©2012 AACR.Keywords
All Related Versions
This publication has 50 references indexed in Scilit:
- Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and PrognosisClinical Cancer Research, 2011
- miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1Molecular Cancer Research, 2011
- Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastasesCancer Letters, 2011
- CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced AngiogenesisClinical Cancer Research, 2010
- Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosisOncogene, 2010
- Snail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung CarcinomaClinical Cancer Research, 2009
- Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expressionGenes & Development, 2009
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancersOncogene, 2008
- The Human let-7a-3 Locus Contains an Epigenetically Regulated MicroRNA Gene with Oncogenic FunctionCancer Research, 2007